Educational governance for the regulation of industry sponsored continuing medical education in interventional and device based therapies

Heart

Volumn 91, Issue 6, 2005, Pages 710-712

  Morgan, John M ^a   Marco, J ^b   Stockx, L ^c   Zannad, F ^d  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b Unite de Cardiologie Interventional Department   (France)

^c DEPARTMENT OF CARDIOLOGY   (Belgium)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONTINUING EDUCATION; DEVICE; ETHICS; EUROPEAN UNION; IMPLANTATION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MEDICAL EDUCATION; PRIORITY JOURNAL; RESEARCH; REVIEW; TEACHING;

BIOETHICS AND PROFESSIONAL ETHICS; BIOMEDICAL AND BEHAVIORAL RESEARCH;

BIOMEDICAL RESEARCH; DRUG INDUSTRY; EDUCATION, MEDICAL, CONTINUING; EQUIPMENT AND SUPPLIES; EUROPEAN UNION; HUMANS; INTERPROFESSIONAL RELATIONS; TECHNOLOGY, MEDICAL; TRAINING SUPPORT;

EID: 20044393555     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.046839     Document Type: Review

References (19)

1. Komesaroff PA, Kerridge IH. Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry. Med J Australia 2002;176:118-21.
2. Boyce KJ, Parochka J, Overstreet K. Industry sponsorship of continuing medical education. JAMA 2003;290:1149.
3. Frewer A. Sponsorship, conflict of interest and corruption: promoting science in discussion of medical ethics. Wien Med Wochenschr 2002;152(9-10):234-7.
4. Skolnick A. FDA issues draft 'concept paper' on drug company funding of CME. JAMA 1991;266:2947-8.
5. Rosner F. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines. Mt Sinai J Med 1995;62:427-30.
6. Monbiot G. Guard dogs of perception: the corporate takeover of science. Sci Eng Ethics 2003;9:49-57.
7. Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med 2003;163:2213-8.
8. Rothman KJ. The ethics of research sponsorship. J Clin Epidemiol 1991;44(suppl 1):25S-28S.
9. LSMS Committee on Medical Education. Survey of hospitals and healthcare provider organizations-requirements for physician continuing medical education credits in Louisiana. J La State Med Soc 1999;151:151-3.
10. DelSignore JL. Current guidelines regarding industry-sponsored continuing medical education. Clin Orthop 2003;(412):21-7.
11. Domanski MJ, Sabeena S, Epstein AE, et al. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics versus implantable defibrillators. J Am Coll Cardiol 1999;34:1090-5.
12. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
13. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
14. Bryan J. Sponsorship. No such thing as a free lunch? Health Serv J 1995;105:22-5.
15. Sullivan R. United Kingdom research governance strategy: reforming clinical research and development in England. BMJ 2004;328:49-50.
16. Wetlz DK. Lessons from comparing CME accreditation in Europe and the United States, Eur J Cancer 2003;39:2422-3.
17. Davis D, Parboosingh J. "Academic" CME and the social contract. Acad Med 1993;68:329-32.
18. European Union of Medical Specialists. Dublin Declaration. Update 1993, Funchal meeting, CP 93/026.
19. Michels HR. Continuing Medical Education in Europe: NWC, CVOI, ESC, UEMS, and EBAC. Netherlands Heart Journal 2001;9:1-5.